Melissa Moore
Inventor
Stats
- 13 US patents issued
- 25 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 13 US Patents Issued
- 25 US Applications Filed
- 541 Total Citation Count
- Apr 12, 2022 Most Recent Filing
- Sep 22, 2003 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
UNIVERSITY OF MASSACHUSETTS | 2
| 2016
|
PACESETTER, INC. | 1
| 2003
|
RXI PHARMACEUTICALS CORPORATION | 2
| 2016
|
MATTERSIGHT CORPORATION | 4
2 6 2 2 5 2 | 2005
2011 2013 2014 2015 2016 2017 |
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 2
| 2016
|
SOFIE BIOSCIENCES, INC. | 1
1 | 2015
2017 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1
1 1 | 2014
2015 2017 |
Inventor Addresses
Address | Duration |
---|---|
Beverly Hills, CA, US | Mar 08, 18 - Mar 17, 20 |
Cambridge, MA, US | Sep 22, 22 - Sep 22, 22 |
Chestnut Hill, MA, US | Dec 08, 16 - Nov 17, 22 |
Chicago, IL | Nov 23, 06 - Nov 23, 06 |
Chicago, IL, US | Aug 09, 11 - Jun 22, 21 |
Culver City, CA, US | Apr 13, 17 - Nov 12, 19 |
Greenville, SC | Jan 30, 07 - Jan 30, 07 |
Los Angeles, CA, US | Sep 29, 16 - Sep 25, 18 |
Technology Profile
Technology | Matters | |
---|---|---|
A61B: | DIAGNOSIS; SURGERY; IDENTIFICATION | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
B01J: | CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2022/0364,100 | 2022 | OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS | 10 |
2022/0298,516 | 2022 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS | 0 |
11345917 | 2022 | Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders | 10 |
11043136 | 2021 | Personality-type training system and methods | 0 |
2020/0165,618 | 2020 | OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS | 11 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.